Safety and tolerability of andecaliximab as monotherapy and in combination with an anti-PD-1 antibody in Japanese patients with gastric or gastroesophageal junction adenocarcinoma: a phase 1b study
oleh: Atsuo Takashima, Narikazu Boku, Taroh Satoh, Shigenori Kadowaki, Kei Muro, Shigehisa Kitano, Kensei Yamaguchi, Keisho Chin, Marianna Zavodovskaya, Dung Thai, Akie Kimura Yoshikawa, Takashi Ichimura, Daisuke Sakai, Toshihiro Kudo, Seiichiro Mitani, JieJane Liu
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2022-01-01 |
Deskripsi
No description available for this item.